RE:RE:Don't Drink the cool aidNorish, is a earnout not a debt? it was their final payment and thus the company is no longer in "debt" to civen. we are comparing stones and rocks here, don't focus on the irrelavent. Also as far as "debts vs assets" go concordia is certainly doing much better than many other companies in its feild. Vaient is negative billions of dollars in debt by your calculation in fact most major drug companies are billions and billions of dollars, in debt, and is that a bad thing? no. its called leverage. you use your debt to aquire assets and proliferate the overall value of your company. infact sometimes its even more attractive for a company to get more debt to help aquire profitable assets. concordia is a doing a little bit of both, it has paid back its earnout payment, to civen with interest. on top of this it has invested more than 100 million dollars into research for new drugs and has plans to rool out 60 new products by 2018. of course it does research its a pharmacetical company with brands under its wings, it really annoys me to see weak kneed investors like yourself trying to scare long sellers into selling all of their shares so you people can buy it all up and ride the train to the top in the next few months/ 2018. not buying your nonsense, and not selling my stock.
-400 million dollars in pure liquid assets, hundreds of millions more in assets and new medicine coming up, yeah this is such a terrible stock with no future (sarcasm)
https://concordiarx.com/release/?id=122578
-bbc made a news report about a week ago about concerns that concordia was wasting too much money on research
-you know nothing about this stock, at least i do the research, i'm not gonna cite everything because you refuse to say anything good about this stock regardless, but look this stuff up and take notes before given anyone frivilous advice.